A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection

Stopped early

Conditions studied: Covid19

In brief

The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.

Key facts

Study ID

NCT04725097

Run by

Mayo Clinic

People needed

2821

Starts

2020-12-10

Expected to finish

2021-06-03

Last updated by the study team

2021-09-09

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult males and females age 18 or greater.
• Undergoing COVID-19 testing by PCR.
• Willing and able to provide informed consent.
• Pregnant females (minimal risk study, no risk from ECG).

You may not qualify if…

• Unwilling or unable to provide informed consent.

Where it is running

• Mayo Clinic — Phoenix, Arizona, United States
• Mayo Clinic — Jacksonville, Florida, United States
• LSUHSC Shreveport — Shreveport, Louisiana, United States
• Henry Ford Health System — West Bloomfield, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Hackensack Meridian Health — Hackensack, New Jersey, United States
• Sri Jayadeva — Bengaluru, Karnataka, India
• King Edward Memorial Hospital — Mumbai, Maharashtra, India
• Gregorio Marañon Hospital — Madrid, Spain
• Imperial College — London, England, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.